CCS Impact Grants – Letter of Intent (LOI)
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire with your unit
Memorial Deadline: No RGCS review required for the Letter of Intent
External Deadline: Wednesday 29th, April 2020
Description
The Impact Grant program supports significant progression in cancer research programs that are anywhere in the continuum from basic, high impact discovery to translational work of direct relevance to the clinic, to applied research. Impact Grants aim to accelerate and focus the knowledge gained from scientific findings, in the short- to medium-term, into outcomes that will:
- * significantly improve scientific knowledge relevant to cancer;
- * result in improved cancer treatment;
- * result in optimized care of people living with and beyond cancer;
- * result in reduced cancer burden.
Impact Grants provide funding to support ideas that promote major advancements in research programs, whether at the fundamental discovery stage (such as studies involving model organisms that demonstrate potential for impact) through to applied research (such as patient or population-based proposals). Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, and social and population health research.
Impact grants are not intended to support incremental scientific advances and are not intended to solely support research infrastructure.
Impact grants have been created to cultivate and support programs in cancer research that have the potential to significantly impact the burden of disease in patients and populations. The goal of the CCS Research Impact Grant program is to provide a mechanism for scientists to accelerate the application of new knowledge and apply innovations to address important problems in cancer research and care.
LOI due date: April 29, 2020
LOI results: late June 2020
Application due date: September 15, 2020
Results announcement: December 2020
Anticipated start date: February 1, 2021
Additional information can be found here.